Medipharm Labs Corp (MEDIF) Financial Statements

MEDIF Financial Data

EBITDA—

Revenue (TTM)—

Gross Profit (TTM)—

Gross Margin—

Operating Margin—

ROE—

ROA—

Debt/Equity—

Current Ratio—

FCF—

FCF Yield—

Piotroski F-Score—

Rev/Share (TTM)—

50-Day MA$0.05

200-Day MA$0.05

Shares Outstanding—

MEDIF Computed Insights

FCF—

FCF Growth Rate—

EPS Growth (CAGR)—

WACC10.00%

Income Statement

Balance Sheet

Cash Flow Statement

MEDIF Financial Statements & Data

Medipharm Labs Corp (MEDIF) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Medipharm Labs Corp's financial performance and position.

Weighted average cost of capital (WACC) is 10.00%.

GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.

Use Medipharm Labs Corp's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.